- People infected with even mild cases of COVID-19 remain at heightened risk for heart problems, blood clots, diabetes, neurologic complications, and other health problems for up to two years, according to a new study. Studies have examined the symptoms that have become known as “long COVID,” but the analysis published Monday in the journal Nature Medicine purports to be the first to track the risks of those issues beyond a few months or even a year post-infection. (Article here)
- On Monday, the Food and Drug Administration (FDA) approved the first vaccine for pregnant patients to protect infants against respiratory syncytial virus. The shot from Pfizer would give built-in protection against RSV to newborns when they’re most vulnerable to a virus that’s a leading cause of death for infants worldwide. Pfizer’s vaccine, which was previously approved for older adults, would protect infants from severe RSV in their first six months by creating antibodies that neutralize the virus and can be transferred in the womb. (Articles here, here, and here)
September 11, 2023
Life Sciences | Tea Leaves